Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.

Published on Sep 22, 2016in PLOS ONE3.24
· DOI :10.1371/JOURNAL.PONE.0162879
Susanne Tewes9
Estimated H-index: 9
(MHH: Hannover Medical School),
Nikolaj Mokov1
Estimated H-index: 1
+ 7 AuthorsKatja Hueper22
Estimated H-index: 22
(MHH: Hannover Medical School)
Introduction Objective of our study was to determine the agreement between version 1 (v1) and v2 of the Prostate Imaging Reporting and Data System (PI-RADS) for evaluation of multiparametric prostate MRI (mpMRI) and to compare their diagnostic accuracy, their inter-observer agreement and practicability. Material and Methods mpMRI including T2-weighted imaging, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE) of 54 consecutive patients, who subsequently underwent MRI-guided in-bore biopsy were re-analyzed according to PI-RADS v1 and v2 by two independent readers. Diagnostic accuracy for detection of prostate cancer (PCa) was assessed using ROC-curve analysis. Agreement between PI-RADS versions and observers was calculated and the time needed for scoring was determined. Results MRI-guided biopsy revealed PCa in 31 patients. Diagnostic accuracy for detection of PCa was equivalent with both PI-RADS versions for reader 1 with sensitivities and specificities of 84%/91% (AUC = 0.91 95%CI[0.8–1]) for PI-RADS v1 and 100%/74% (AUC = 0.92 95% CI[0.8–1]) for PI-RADS v2. Reader 2 achieved similar diagnostic accuracy with sensitivity and specificity of 74%/91% (AUC = 0.88 95%CI[0.8–1]) for PI-RADS v1 and 81%/91% (AUC = 0.91 95%CI[0.8–1]) for PI-RADS v2. Agreement between scores determined with different PI-RADS versions was good (reader 1: κ = 0.62, reader 2: κ = 0.64). Inter-observer agreement was moderate with PI-RADS v2 (κ = 0.56) and fair with v1 (κ = 0.39). The time required for building the PI-RADS score was significantly lower with PI-RADS v2 compared to v1 (24.7±2.3 s vs. 41.9±2.6 s, p<0.001). Conclusion Agreement between PI-RADS versions was high and both versions revealed high diagnostic accuracy for detection of PCa. Due to better inter-observer agreement for malignant lesions and less time demand, the new PI-RADS version could be more practicable for clinical routine.
📖 Papers frequently viewed together
#1H.A. Vargas (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 9
#2Andreas M. Hötker (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 13
Last. Hedvig Hricak (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 137
view all 12 authors...
Objectives To evaluate the recommendations for multiparametric prostate MRI (mp-MRI) interpretation introduced in the recently updated Prostate Imaging Reporting and Data System version 2 (PI-RADSv2), and investigate the impact of pathologic tumour volume on prostate cancer (PCa) detectability on mpMRI.
#4Chris H. Bangma (Erasmus University Medical Center)H-Index: 85
Context: Multiparametric magnetic resonance imaging (MRI) of the prostate may improve the diagnostic accuracy of prostate cancer detection in MRI-targeted biopsy (MRI-TBx) in comparison to transrectal ultrasound-guided biopsy (TRUS-Bx). Objective: Systematic review and meta-analysis of evidence regarding the diagnostic benefits of MRI-TBx versus TRUS-Bx in detection of overall prostate cancer (primary objective) and significant/insignificant prostate cancer (secondary objective). Evidence acquis...
#1Massimo Valerio (UCL: University College London)H-Index: 24
#2Ian Donaldson (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 8
Last. Hashim U. Ahmed (UCL: University College London)H-Index: 64
view all 9 authors...
Abstract Context The current standard for diagnosing prostate cancer in men at risk relies on a transrectal ultrasound–guided biopsy test that is blind to the location of the cancer. To increase the accuracy of this diagnostic pathway, a software-based magnetic resonance imaging–ultrasound (MRI-US) fusion targeted biopsy approach has been proposed. Objective Our main objective was to compare the detection rate of clinically significant prostate cancer with software-based MRI-US fusion targeted b...
#1Berrend G. Muller (NIH: National Institutes of Health)H-Index: 16
#2Joanna H. ShihH-Index: 35
Last. Baris TurkbeyH-Index: 80
view all 12 authors...
The Prostate Imaging Reporting and Data System (PI-RADS) is an important standardization tool for reporting multiparametric MR imaging results; in this study the authors show that, like the first version of PIRADS, the second version is only moderately reproducible.
#1E.H.J. Hamoen (Radboud University Nijmegen Medical Centre)H-Index: 7
#2Maarten de Rooij (Radboud University Nijmegen Medical Centre)H-Index: 13
Last. Maroeska M. Rovers (Radboud University Nijmegen Medical Centre)H-Index: 50
view all 5 authors...
Context: In 2012, an expert panel of the European Society of Urogenital Radiology (ESUR) published the Prostate Imaging Reporting and Data System (PI-RADS) for prostate cancer (PC) detection with multiparametric magnetic resonance imaging (mp-MRI). Since then, many centers have reported their experiences. Purpose: To review the diagnostic accuracy of PI-RADS for PC detection with mp-MRI. Evidence acquisition: We searched Medline and Embase up to March 20, 2014. We included diagnostic accuracy st...
#1Eduard Baco (SC: University of Southern California)H-Index: 17
#2Osamu Ukimura (SC: University of Southern California)H-Index: 53
Last. Inderbir S. Gill (SC: University of Southern California)H-Index: 139
view all 13 authors...
Abstract Background Prostate biopsies targeted by elastic fusion of magnetic resonance (MR) and three-dimensional (3D) transrectal ultrasound (TRUS) images may allow accurate identification of the index tumor (IT), defined as the lesion with the highest Gleason score or the largest volume or extraprostatic extension. Objective To determine the accuracy of MR-TRUS image-fusion biopsy in characterizing ITs, as confirmed by correlation with step-sectioned radical prostatectomy (RP) specimens. Desig...
#1Susanne Tewes (MHH: Hannover Medical School)H-Index: 9
#2Katja Hueper (MHH: Hannover Medical School)H-Index: 22
Last. Inga Peters (MHH: Hannover Medical School)H-Index: 14
view all 10 authors...
Purpose To evaluate a novel system for MRI/TRUS fusion-guided biopsy for detection of prostate cancer (PCa) in patients with previous negative prostate biopsy and determine diagnostic accuracy when using the Prostate Imaging Reporting and Data System (PI-RADS) for multiparametric magnetic resonance imaging (mpMRI) as proposed by the European Society of Urogenital Radiology.
#1Lars SchimmöllerH-Index: 15
#2Michael QuentinH-Index: 20
Last. Dirk BlondinH-Index: 34
view all 9 authors...
Purpose This study evaluated the accuracy of MR sequences [T2-, diffusion-weighted, and dynamic contrast-enhanced (T2WI, DWI, and DCE) imaging] at 3T, based on the European Society of Urogenital Radiology (ESUR) scoring system [Prostate Imaging Reporting and Data System (PIRADS)] using MR-guided in-bore prostate biopsies as reference standard. Methods In 235 consecutive patients [aged 65.7±7.9 years; median prostate-specific antigen (PSA) 8 ng/ml] with multiparametric prostate MRI (mp-MRI), 566 ...
#1Matthias Roethke (DKFZ: German Cancer Research Center)H-Index: 27
#2Timur H. Kuru (University Hospital Heidelberg)H-Index: 16
Last. Boris Hadaschik (University Hospital Heidelberg)H-Index: 57
view all 8 authors...
Objectives To evaluate the Prostate Imaging Reporting and Data System (PI-RADS) proposed by the European Society of Urogenital Radiology (ESUR) for detection of prostate cancer (PCa) by multiparametric magnetic resonance imaging (mpMRI) in a consecutive cohort of patients with magnetic resonance/transrectal ultrasound (MR/TRUS) fusion-guided biopsy.
#1Maarten de Rooij (Radboud University Nijmegen Medical Centre)H-Index: 13
#2E.H.J. HamoenH-Index: 7
Last. Maroeska M. RoversH-Index: 50
view all 5 authors...
OBJECTIVE. The purpose of this diagnostic meta-analysis was to determine the diagnostic accuracy of multiparametric MRI for prostate cancer detection using anatomic T2-weighted imaging combined with two functional techniques: diffusion-weighted imaging (DWI) and dynamic contrast-enhanced MRI (DCE-MRI). MATERIALS AND METHODS. We searched electronic databases, including MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) up to February 3, 2012. We included diagnostic ...
Cited By35
#1Yongkai LiuH-Index: 4
Last. Kyunghyun SungH-Index: 19
view all 10 authors...
The current standardized scheme for interpreting MRI requires a high level of expertise and exhibits a significant degree of inter-reader and intra-reader variability. An automated prostate cancer (PCa) classification can improve the ability of MRI to assess the spectrum of PCa. The purpose of the study was to evaluate the performance of a texture-based deep learning model (Textured-DL) for differentiating between clinically significant PCa (csPCa) and non-csPCa and to compare the Textured-DL wi...
#1Jiwoong Yu (SMC: Samsung Medical Center)H-Index: 5
#2Youngjun Boo (SMC: Samsung Medical Center)
Last. Hwang Gyun Jeon (SMC: Samsung Medical Center)H-Index: 22
view all 9 authors...
Purpose We evaluated the negative predictive value (NPV) of multiparametric magnetic resonance imaging (mpMRI) in detecting clinically significant prostate cancer (csPCa) according to biopsy setting and prostate-specific antigen density (PSAD) using transperineal template-guided saturation prostate biopsy (TPB) as the reference standard. Methods A total of 161 patients with biopsy histories and negative pre-biopsy mpMRI (Prostate Imaging Reporting and Data System version 2 scores of less than 3)...
#1Jinman Zhong (Fourth Military Medical University)
#2Weijun Qin (Fourth Military Medical University)H-Index: 22
Last. Jing Ren (Fourth Military Medical University)H-Index: 9
view all 6 authors...
Objective To evaluate urologist satisfaction on structured prostate MRI reports, including report with tumor-node-metastasis (TNM) staging (report B) and with Prostate Imaging Reporting and Data System (PI-RADS) score with/without TNM staging (report C, report with PI-RADS score only [report C-a] and report with PI-RADS score and TNM staging [C-b]) compared with conventional free-text report (report A). Materials and methods This was a prospective comparative study. Altogether, 3015 prostate MRI...
#1Madhuri M. Rudolph (Humboldt University of Berlin)H-Index: 3
#2Alexander D. J. Baur (Humboldt University of Berlin)H-Index: 12
Last. Tobias Penzkofer (Humboldt University of Berlin)H-Index: 22
view all 12 authors...
The purpose of this study is to compare diagnostic performance of Prostate Imaging Reporting and Data System (PI-RADS) version (v) 2.1 and 2.0 for detection of Gleason Score (GS) ≥ 7 prostate cancer on MRI. Three experienced radiologists provided PI-RADS v2.0 scores and at least 12 months later v2.1 scores on lesions in 333 prostate MRI examinations acquired between 2012 and 2015. Diagnostic performance was assessed retrospectively by using MRI/transrectal ultrasound fusion biopsy and 10-core sy...
#1Lili Xu (Peking Union Medical College Hospital)H-Index: 4
#2Gumuyang Zhang (Peking Union Medical College Hospital)H-Index: 9
Last. Hao Sun (Peking Union Medical College Hospital)H-Index: 12
view all 11 authors...
PURPOSE To compare the diagnostic performance of PI-RADS version 2.1 (PI-RADS v2.1) and PI-RADS v2 for transition zone prostate cancer (TZPC), and analyse its performance for readers with different experience levels. METHODS Eighty-five patients with suspected prostate cancer who underwent biopsy after MRI scan between January and December 2017 were retrospectively enrolled. One junior radiologist (reader 1, 1 year of experience in using PI-RADS v2) and one senior radiologist (reader 2, 6 years ...
#1Zhibing Wang (Soochow University (Suzhou))H-Index: 1
#2Wenlu Zhao (Soochow University (Suzhou))H-Index: 3
Last. Yueyue Zhang (Soochow University (Suzhou))H-Index: 3
view all 7 authors...
The studies comparing the versions 2 vs. 2.1 of the Prostate Imaging Reporting and Data System (PI-RADS) are rare. This study aimed to evaluate whether PI-RADS version 2.1 is superior in detecting transition zone prostate cancer in comparison with PI-RADS version 2. This was a diagnostic study of patients with prostate diseases who visited the Urology Department of The Second Affiliated Hospital of Soochow University and underwent a magnetic resonance imaging (MRI) examination between 03-01-2016...
#1Rajan T. Gupta (Duke University)H-Index: 30
#2Kurren Mehta (Duke University)H-Index: 2
Last. Sadhna Verma (UC: University of Cincinnati)H-Index: 26
view all 4 authors...
: Prostate cancer (PCa) is extremely prevalent and is the most common noncutaneous malignancy and second-most common cause of cancer death in men. In the last decade, there has been dramatic growth in the use of multiparametric magnetic resonance imaging (mpMRI) for diagnosis and characterization of PCa. With the recent and marked surge in popularity in prostate imaging and, specifically, mpMRI, there has been an increased focus on structured reporting as a means by which to provide more actiona...
#1Armando Stabile (UniSR: Vita-Salute San Raffaele University)H-Index: 19
#2Francesco Giganti (UCL: University College London)H-Index: 26
Last. Jelle O. Barentsz (Radboud University Nijmegen)H-Index: 94
view all 12 authors...
Abstract Context There is a lack of comprehensive data regarding the factors that influence the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) to detect and localize clinically significant prostate cancer (csPCa). Objective To systematically review the current literature assessing the factors influencing the variability of mpMRI performance in csPCa diagnosis. Evidence acquisition A computerized bibliographic search of Medline/PubMed database was performed for all stud...
#1Valentina BrancatoH-Index: 5
Last. Carlo CavaliereH-Index: 26
view all 7 authors...
The role of dynamic contrast-enhanced-MRI (DCE-MRI) for Prostate Imaging-Reporting and Data System (PI-RADS) scoring is a controversial topic. In this retrospective study, we aimed to measure the added value of DCE-MRI in combination with T2-weighted (T2W) and diffusion-weighted imaging (DWI) using PI-RADS v2.1, in terms of reproducibility and diagnostic accuracy, for detection of prostate cancer (PCa) and clinically significant PCa (CS-PCa, for Gleason Score ≥ 7). 117 lesions in 111 patients we...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.